“We share a deep commitment to innovation and employment generation. By always putting patients first, we can achieve our primary objective: contribution to a healthier and happier life” Javier Peris, President Mission, Vision and Values What Drives Salvat Salvat’s goal is to be a hub in the development of pharmaceutical technologies with a primary focus on Otolaryngology and Ophthalmology. We have a strong calling for innovation. Innovation in the Research and Development unit is the backbone of our company however, each and every employee is called to contribute to the innovative process at Salvat. With the help of a deeply engaged team, Salvat aims for steady growth. The team is aligned with our strategic goals and follows our action plan. Simultaneously, Salvat is committed to providing continued training and stability within a strong work environment. COMPANY VALUES Commitment Motivation fuelled by challenges Ethics Creativity and initiative Development as a team Adaptation and flexibility We want to be a strong company with a foundation in innovation. We want to remain competitive, capable of growth in a global context, maintain our independence, but be open to strategical alliances, with the aim of becoming an attractive referent for the personal and professional development of our partners and employees. The Company Pharma, for the world We are a private capital pharmaceutical company, established in Barcelona in 1955, today managed by the 3rd and 4th generation of the family. As a Company we focus on organic growth, with a long term vision and the purpose of generate innovation and creating jobs. As a family, we manage the Company keeping ethics at its core. Today, with more than 400 employees in Spain, three manufacturing plants in Barcelona, Madrid and Tamarac (Florida), two marketed products in the US and a broad international presence, we envision a great future for Salvat. Our history More than 65 years of innovation Previous Next 1955 Founded Laboratorios Salvat Tomas Miarnau and Dr. Antonio Salvat founded the Company in Barcelona in 1955. Today Salvat is still a family business, led by the descendants of Jose Maria Peris Miarnau, lawyer and nephew of one of the founders, and Elvira Maria Teresa Musso Borras. Company milestones 1984 Move to current HQs 1986 Launch of Cristalmina 1996 Launch of Monolitum 2006 Launch of US operations and products 2017 Expansion of manufacturing through Pharmaloop in Madrid Salvat USA Salvat in the American market In 2006, Salvat began operations in the United States with the establishment of Salvat USA in Miami, Florida. That same year, we received an approval letter for Cetraxal® in the USA and an IND for Tarafenacin. In 2009, the FDA approved Cetraxal® Otic Solution, which we launched in the USA in partnership with WraSer Pharmaceuticals. The US launch of OTOVEL® followed in 2016. OTOVEL® is our flagship prescription product. With a unique formulation and the use of our Blow-Fill-Seal technology, we have achieved long-term IP protection that will allow us to grow in the US market for many years to come. OTOVEL® is commercialized by Arbor Pharmaceuticals in the US market. OTOVEL® is a combination of Ciprofloxacin, a fluoroquinolone antibacterial and the corticosteroid fluocinolone acetonide, indicated for the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients. OTOVEL® is for otic administration only and is presented in single-dose vials (0.25 mL). Otovel® can be used in patients aged 6 months and older. Salvat Worldwide Our international presence In 1982, with the understanding that our growth opportunities would come from beyond our borders, we launched our International Division. Today, our international sales represent approximately 40% of the business and are one of Salvat’s major growth pillars. Salvat has offices in Barcelona, Madrid and Miami, where we also own manufacturing facilities. We have our own marketing and sales structure in Spain, Portugal, Central America and Sub-Saharan Africa and partner with licensees to market our products in Europe, United States, Canada, Mexico, South America, North of Africa, Middle East, India, South East Asia, China and South Korea. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Our People A big family Meet Salvat’s fuel, the people that make success possible every day. Over 400 employees at your disposal. MANAGEMENT TEAM Alberto Bueno CEO Diego Aparicio Industrial Operations Director Jörg Behrendt Commercial Director Spain & Portugal Imma Cervera Qualified Person Isabel Delgado R&D Director Enrique Jiménez Medical & Regulatory Affairs Director Alejandro Ripol CFO & HR Director Patricia Ferriot International & Business Development Director Salvat Mission, Vision & Values The Company Our History Salvat USA Salvat Worldwide Our People Activities R+D Product Pipeline Partnering Manufacturing Pharmaloop Sales Products Otolaryngology Ophthalmology Gastroenterology Other Therapeutic Areas Consumer Healthcare Full Product List Commitment Corporate Citizenship Transparency Memberships Salvat Foundation Careers Working at Salvat Send your CV Media Press Kit News Connect Contact Us Salvat Replies DISCLAIMER COOKIES © SALVAT 2020, ALL RIGHTS RESERVED Usamos 'cookies' para personalizar el contenido y analizar el uso de nuestro sitio web. Si hace clic en "Aceptar", da su consentimiento para el uso de éstas y navegará directamente a la página web. Si no quiere aceptar algunas de las ‘cookies’ o quiere saber más acerca de cómo usamos las ‘cookies’, haga click en “Personalizar”. VER POLÍTICA DE COOKIES We use 'cookies' to personalize content and analyze the use of our website. By clicking "I Accept", you consent to their use and will navigate directly to the website. If you do not want to accept some of the ‘cookies’ or want to know more about how we use the ‘cookies, click on“ Personalize”. VIEW COOKIES POLICY ACEPTAR / I ACCEPT PERSONALIZAR / PERSONALIZE